Structure of Compstatin in Complex with Complement Component C3c Reveals a New Mechanism of Complement Inhibition
Bert J. C. Janssen, Els F. Halff, John D. Lambris et al. · Journal of Biological Chemistry · 2007
Undesired complement activation is a major cause of tissue injury in various pathological conditions and contributes to several immune complex diseases. Compstatin, a 13-residue peptide, is an effective inhibitor of the activation of complement component C3 and thus blocks a central and crucial step in the complement cascade. The precise binding site on C3, the structure in the bound form, and the exact mode of action of compstatin are unknown. Here we present the crystal structure of compstatin in complex with C3c, a major proteolytic fragment of C3. The structure reveals that the compstatin-binding site is formed by the macroglobulin (MG) domains 4 and 5. This binding site is part of the structurally stable MG-ring formed by domains MG 1-6 and is far away from any other known binding site on C3. Compstatin does not alter the conformation of C3c, whereas compstatin itself undergoes a large conformational change upon binding. We propose a model in which compstatin sterically hinders the access of the substrate C3 to the convertase complexes, thus blocking complement activation and amplification. These insights are instrumental for further development of compstatin as a potential therapeutic.
Cited by 130 works. doi:10.1074/jbc.m704587200
Authors
References
- The CCP4 suite: programs for protein crystallography
- Coot : model-building tools for molecular graphics
- Likelihood-enhanced fast translation functions
- Complement
- ISOLATION OF A FRAGMENT (C3a) OF THE THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM
- Use of Non-crystallographic Symmetry in Protein Structure Refinement
- The complement system in regulation of adaptive immunity
- Structures of complement component C3 provide insights into the function and evolution of immunity
- Structure of C3b reveals conformational changes that underlie complement activity
- Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library